
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-10-04-2017
- Volume 12
- Issue 10
BASF Plans Amine Facility in Nanjing
BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China.
BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China, the company announced in a Sept. 25, 2017 press release. The new multi-product plant can manufacture 21,000 metric tons per year and further extends BASF’s amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to come on stream in 2019 and will mainly produce 1,2-Propylenediamine (1,2-PDA), n-Octylamine (n-OA), and Polyetheramine (PEA). 1,2-PDA is a building block in the manufacture of pharmaceuticals as well as other chemicals.
“This investment will help us to meet the increasing Asia Pacific demand for specialty amines used as intermediates in a diverse range of industries …,” said Narayan Krishnamohan, senior vice-president, Intermediates Asia Pacific, BASF, in the press release. “Through this expansion, we will be able to better serve our customers in Asia Pacific with steady and timely supply of quality products.”
BASF also has manufacturing capacities for both 1,2-PDA and n-OA at its Ludwigshafen Verbund site in Germany.
Source:
Articles in this issue
about 8 years ago
Finding a New Purpose for an Unproven Drugabout 8 years ago
Demand for Efficiency Spurs Bioprocessing Innovationabout 8 years ago
Fresenius Kabi Breaks Ground on $250-Million Facility Expansionabout 8 years ago
UPS Reveals Supply Chain Security Systemabout 8 years ago
Cambrex Adds Reactors to Facility in Swedenabout 8 years ago
ADC Bio Invests $11 Million on Bioconjugation Facilityabout 8 years ago
Software Adds Data Integrity Functionsabout 8 years ago
Particle Analyzer Images Nanoparticlesabout 8 years ago
Global Effort to Stop Sale of Illegal Drugs Advancesabout 8 years ago
Eurofins Scientific to Acquire EAG LabsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





